Image by pen_ash on Pixabay · Pixabay License
deCODE Genetics
Sign in to saveAlso known as Íslensk erfðagreining, deCODE genetics, Inc.
compagnie biopharmaceutique basée à Reykjavik
OverviewAI-generated
deCODE genetics is a public company and biobank founded by Kári Stefánsson in 1996. The organization operates within the biopharmaceutical industry and is classified as a business entity. It maintains its headquarters in Reykjavík, Iceland.
The company is listed on the Nasdaq stock exchange. Its operations involve commercial physical and biological research. The entity type is described as operating, with a fiscal year end on December 31. The organization was incorporated in Delaware.
Synthesized by Vinony from 26 facts across 4 sources: Wikidata, Firecrawl, SEC EDGAR, ROR. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Company
- Industry
- Services-Commercial Physical & Biological Research
- State of incorporation
- DE
- Entity type
- operating
- Latest filing
- 15-12G · 2010-07-07
via SEC EDGAR
Research organization · ROR
- Type
- Company
- Founded
- 1996
- Location
- Reykjavik, Iceland
- Status
- Active
GRID grid.421812.c · ISNI 0000 0004 0618 6889
Wikidata facts
- Instance of
- biobank
- Country
- Iceland
- Founded by
- Kári Stefánsson
- Headquarters
- Reykjavík
- Industry
- biopharmaceutical
- Stock exchange
- Nasdaq
- Official website
- www.decode.com
- Image
- Íslensk Erfðagreining (31027920356).jpg
Show 2 more facts
- inception
- 1996-00-00
- Commons category
- Íslensk erfðagreining
Sources (3)
via Wikidata · CC0
Article · Français
deCODE Genetics (en islandais : Íslensk erfðagreining, c-à-d "Analyse génétique islandaise") est une compagnie biopharmaceutique basée à Reykjavik. La compagnie applique ses découvertes en génétique à la création de médicaments. Elle a réussi à isoler des gènes responsables de maladies telles que certaines schizophrénies ou cancers. L'isolation de gènes permet le développement de médicaments. Des études cliniques sont en cours pour des médicaments contre l'artériosclérose et l'asthme. L'action était cotée NASDAQ sous le code DCGN.
Abstract from DBpedia / Wikipedia · CC BY-SA